Phase I and pharmacologic study of the macromolecular topoisomerase-1-inhibitor DE-310 given once every 2 or 6 weeks in patients with solid tumorsO Soepenberg,MJA De Jonge,WJ Loos,A Sparreboom,FALM Eskens,G De Heus,S Elliott, P Cheverton, L Bastien,J VerweijEUROPEAN JOURNAL OF CANCER（2002）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
